Loading...
News 2017-07-15T01:04:34+00:00

Categories

Archives

IVI Demonstrates Commitment to Patient Involvement with Release of “Partnering with Patients” Principles

To demonstrate IVI’s commitment to patient involvement and ensure that the patient perspective is represented in our work, IVI recently developed several documents enumerating the principles and practices that guide this vital partnership. These documents offer detail about the [...]

April 17th, 2018|IVI News|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health [...]

April 16th, 2018|IVI News, Research|

Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play [...]

April 11th, 2018|Viewpoints|

Using Outcomes-Based Pricing for Medical Devices to Improve Cardiovascular Disease Treatment Value

In a post on the IVI-sponsored Health Affairs featured blog series Drugs and Medical Innovation, Daniel Blumenthal, Samuel Nussbaum (IVI Strategic Advisory Panel Chair), Mark Linthicum (IVI Director of Scientific Communications), and Neil Weissman (IVI [...]

March 29th, 2018|Viewpoints|

IVI Names Veteran Health Care Strategist Jennifer Bright as New Acting Executive Director

Bright Brings Decades of Health Care Experience and Established Relationships to IVI Los Angeles, CA - March 5, 2018 - The Innovation and Value Initiative (IVI) - a collaboration dedicated to developing better approaches [...]

March 5th, 2018|IVI News, Press|

IVI Report Examines Imbalances in Health Care Effectiveness Analyses

A new Innovation and Value Initiative (IVI) report found that cost-effectiveness analyses (CEAs) are disproportionately conducted on pharmaceutical interventions compared to other health care treatments. Learn more about what causes this and the potential policy [...]

February 21st, 2018|IVI News, Research|

To Get Our Money’s Worth in Healthcare, We Need to Collaborate

In a commentary for Modern Healthcare, IVI Director of Scientific Communications, Mark Linthicum, emphasizes that the healthcare system needs to embrace collaboration to find consensus in the way we measure and pay for health care [...]

January 22nd, 2018|Viewpoints|

Open-Source Rx Value Model Designed To Encourage ‘More Productive’ Discussions

Pink Sheet Senior Writer, Cathy Kelly, reports on the goals and objectives of the IVI Open-Source Value Project (OSVP), how the first iteration of the tool on rheumatoid arthritis is intended to serve different health [...]

January 22nd, 2018|Press|

Well-Informed Patients Play a Key Role in Value-Based Care

In a commentary for Morning Consult, Virginia Ladd, President and Executive Director of the American Autoimmune Related Diseases Association (AARDA), emphasizes how critical it is that the patient perspective be front and center in discussions [...]

January 12th, 2018|Viewpoints|